These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 8094549)
1. Recent advances in the pathophysiology of primary immune deficiencies and immunoglobulin therapy in HIV infection and autoimmune/inflammatory neurological disorders. Symposium proceedings. Indian Wells, California, January 24-25, 1992. Pediatr Res; 1993 Jan; 33(1 Suppl):S1-100. PubMed ID: 8094549 [No Abstract] [Full Text] [Related]
3. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. Orange JS; Hossny EM; Weiler CR; Ballow M; Berger M; Bonilla FA; Buckley R; Chinen J; El-Gamal Y; Mazer BD; Nelson RP; Patel DD; Secord E; Sorensen RU; Wasserman RL; Cunningham-Rundles C; J Allergy Clin Immunol; 2006 Apr; 117(4 Suppl):S525-53. PubMed ID: 16580469 [TBL] [Abstract][Full Text] [Related]
13. [The use of immunoglobulin preparations in clinical practice]. Monova D Vutr Boles; 1991; 30(1):19-25. PubMed ID: 1771855 [No Abstract] [Full Text] [Related]
14. Intravenous immunoglobulin, immunodeficiency syndromes and idiopathic thrombocytopenic purpura. Proceedings of a workshop. Edinburgh, Scotland, 4 and 5 December 1986. J Infect; 1987 Jul; 15 Suppl 1():1-65. PubMed ID: 3117895 [No Abstract] [Full Text] [Related]
15. [Indications for intravenous immunoglobulins]. Spertini F Rev Med Suisse Romande; 1993 Mar; 113(3):179-82. PubMed ID: 8480110 [No Abstract] [Full Text] [Related]
16. Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America. Condino-Neto A; Costa-Carvalho BT; Grumach AS; King A; Bezrodnik L; Oleastro M; Leiva L; Porras O; Espinosa-Rosales FJ; Franco JL; Sorensen RU Allergol Immunopathol (Madr); 2014; 42(3):245-60. PubMed ID: 23333411 [TBL] [Abstract][Full Text] [Related]
17. Managing patients with side effects and adverse events to immunoglobulin therapy. Azizi G; Abolhassani H; Asgardoon MH; Shaghaghi S; Negahdari B; Mohammadi J; Rezaei N; Aghamohammadi A Expert Rev Clin Pharmacol; 2016; 9(1):91-102. PubMed ID: 26496172 [TBL] [Abstract][Full Text] [Related]
18. [Indications and mechanisms of action of the intravenous immunoglobulines in the systemic autoimmune and inflammatory pathologies]. Mouthon L; Bussone G; Kaveri S Rev Med Interne; 2009 Dec; 30(12 Suppl):H14-20. PubMed ID: 19995651 [TBL] [Abstract][Full Text] [Related]
19. [The clinical use of polyvalent immunoglobulin preparations]. Zimmermann S; Liebert A Z Gesamte Inn Med; 1988 Dec; 43(24):711-2. PubMed ID: 3070976 [TBL] [Abstract][Full Text] [Related]